Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


20.11.2017

2 Actas Urol Esp
1 Biochem Biophys Res Commun
1 Biomed Res Int
2 BMC Cancer
2 Cancer Cell
1 Cancer Immunol Immunother
1 Cell Death Dis
1 Cell Physiol Biochem
1 Curr Urol Rep
1 Diabetes Res Clin Pract
1 Elife
1 Eur Urol
1 Int J Biol Markers
1 Int J Nanomedicine
1 J Urol
1 Jpn J Clin Oncol
1 Medicine (Baltimore)
2 Nat Rev Urol
1 Oncoimmunology
1 Oncol Lett
2 Sci Rep
1 Urol Oncol
1 Urology
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Actas Urol Esp

  1. RODRIGUEZ FABA O, Palou J, Vila Reyes H, Guirado L, et al
    Treatment options and predictive factors for recurrence and cancer-specific mortality in bladder cancer after renal transplantation: A multi-institutional analysis.
    Actas Urol Esp. 2017 Nov 7. pii: S0210-4806(17)30176.
    PubMed     Text format     Abstract available

  2. UNDA-URZAIZ M, Fernandez-Gomez JM, Cozar-Olmos JM, Juarez A, et al
    Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer.
    Actas Urol Esp. 2017 Nov 9. pii: S0210-4806(17)30180.
    PubMed     Text format    


    Biochem Biophys Res Commun

  3. XIAN S, Shang D, Kong G, Tian Y, et al
    FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect.
    Biochem Biophys Res Commun. 2017 Nov 9. pii: S0006-291X(17)32241.
    PubMed     Text format     Abstract available


    Biomed Res Int

  4. HU Q, Wang G, Peng J, Qian G, et al
    Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways.
    Biomed Res Int. 2017;2017:3781904.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. TOLKACH Y, Stahl AF, Niehoff EM, Zhao C, et al
    YRNA expression predicts survival in bladder cancer patients.
    BMC Cancer. 2017;17:749.
    PubMed     Text format     Abstract available

  6. TAN WS, Feber A, Dong L, Sarpong R, et al
    DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
    BMC Cancer. 2017;17:767.
    PubMed     Text format     Abstract available


    Cancer Cell

  7. MEEKS JJ, Lerner SP
    Molecular Landscape of Non-Muscle Invasive Bladder Cancer.
    Cancer Cell. 2017;32:550-551.
    PubMed     Text format     Abstract available

  8. HURST CD, Alder O, Platt FM, Droop A, et al
    Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
    Cancer Cell. 2017;32:701-715.
    PubMed     Text format     Abstract available


    Cancer Immunol Immunother

  9. BREYER J, Wirtz RM, Otto W, Erben P, et al
    High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.
    Cancer Immunol Immunother. 2017 Nov 17. doi: 10.1007/s00262-017-2093.
    PubMed     Text format     Abstract available


    Cell Death Dis

  10. LIU JY, Dai YB, Li X, Cao K, et al
    Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-kappaB/MMP-7 signaling pathway.
    Cell Death Dis. 2017;8:e2691.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  11. LI HJ, Sun XM, Li ZK, Yin QW, et al
    LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
    Cell Physiol Biochem. 2017;43:2548-2561.
    PubMed     Text format     Abstract available


    Curr Urol Rep

  12. LEIBLICH A
    Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer.
    Curr Urol Rep. 2017;18:100.
    PubMed     Text format     Abstract available


    Diabetes Res Clin Pract

  13. DAVIDSON MB, Pan D
    An Updated Meta-Analysis of Pioglitazone Exposure and Bladder Cancer and Comparison to the Drug's Effect on Cardiovascular Disease and Non-Alcoholic Steatohepatitis.
    Diabetes Res Clin Pract. 2017 Nov 13. pii: S0168-8227(17)31438.
    PubMed     Text format     Abstract available


    Elife

  14. HALSTEAD AM, Kapadia CD, Bolzenius J, Chu CE, et al
    Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.
    Elife. 2017;6.
    PubMed     Text format     Abstract available


    Eur Urol

  15. LINSCOTT JA, Smith AB, Sammon JD
    Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
    Eur Urol. 2017 Nov 9. pii: S0302-2838(17)30971.
    PubMed     Text format    


    Int J Biol Markers

  16. POZZI V, Di Ruscio G, Sartini D, Campagna R, et al
    Clinical performance and utility of a NNMT-based urine test for bladder cancer.
    Int J Biol Markers. 2017 Nov 11:0. doi: 10.5301/ijbm.5000311.
    PubMed     Text format     Abstract available


    Int J Nanomedicine

  17. SMILOWITZ HM, Tarmu LJ, Sanders MM, Taylor JA 3rd, et al
    Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.
    Int J Nanomedicine. 2017;12:7937-7946.
    PubMed     Text format     Abstract available


    J Urol

  18. CHANG SS
    Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Urol. 2017;198:1208.
    PubMed     Text format    


    Jpn J Clin Oncol

  19. NISHIYAMA H
    Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.
    Jpn J Clin Oncol. 2017 Nov 14:1-4. doi: 10.1093.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  20. XU Y, Huo R, Chen X, Yu X, et al
    Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.
    Medicine (Baltimore). 2017;96:e8588.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  21. FELSENSTEIN KM, Theodorescu D
    Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.
    Nat Rev Urol. 2017 Nov 14. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available

  22. STONE L
    Bladder cancer: Context is key: dual roles of ANGPTL4.
    Nat Rev Urol. 2017 Nov 14. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Oncoimmunology

  23. LE GOUX C, Vacher S, Pignot G, Sibony M, et al
    mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.
    Oncoimmunology. 2017;6:e1358330.
    PubMed     Text format     Abstract available


    Oncol Lett

  24. ZHANG HH, Huang B, Cao YH, Li Q, et al
    Role of 5-Aza-CdR in mitomycin-C chemosensitivity of T24 bladder cancer cells.
    Oncol Lett. 2017;14:5652-5656.
    PubMed     Text format     Abstract available


    Sci Rep

  25. PENG C, Li A, Wang M
    Discovery of Bladder Cancer-related Genes Using Integrative Heterogeneous Network Modeling of Multi-omics Data.
    Sci Rep. 2017;7:15639.
    PubMed     Text format     Abstract available

  26. QU H, Zheng Y, Wang Y, Zhang R, et al
    Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.
    Sci Rep. 2017;7:15804.
    PubMed     Text format     Abstract available


    Urol Oncol

  27. HERMANS TJN, Voskuilen CS, van der Heijden MS, Schmitz-Drager BJ, et al
    Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.
    Urol Oncol. 2017 Nov 8. pii: S1078-1439(17)30551.
    PubMed     Text format     Abstract available


    Urology

  28. GARRIDO-ABAD P, Diaz-Menendez A, Fernandez-Arjona M
    Bladder Herpes Infection in a Patient with Low-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 13. pii: S0090-4295(17)31175.
    PubMed     Text format     Abstract available


    World J Urol

  29. MARI A, Campi R, Tellini R, Gandaglia G, et al
    Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
    World J Urol. 2017 Nov 16. doi: 10.1007/s00345-017-2115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: